Proficio Capital Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Proficio Capital Partners’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-55	Closed	-$1K	–	1722
2019 Q2	$1K	Sell	55 -111	-67%	-$2.01K	﹤0.01%	1865
2019 Q1	$4K	Buy	+166	New	+$4.16K	﹤0.01%	1204
2018 Q3	–	Sell	-14	Closed	-$1K	–	1320
2018 Q2	$1K	Hold	14	–	–	﹤0.01%	1249
2018 Q1	$1K	Hold	14	–	–	﹤0.01%	1246
2017 Q4	$1K	Hold	14	–	–	﹤0.01%	1243
2017 Q3	$1K	Hold	14	–	–	﹤0.01%	1241
2017 Q2	$1K	Buy	14 +4	+40%	+$245	﹤0.01%	1240
2017 Q1	$1K	Buy	+10	New	+$608	﹤0.01%	1270

Other funds holding CLVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Proficio Capital Partners's CLVS Position: Q3 2019 in Review

Proficio Capital Partners sold out of Clovis Oncology, Inc. (CLVS) in Q3 2019, closing a stake of 55 shares — an estimated $1K sold.

Proficio Capital Partners first reported a position in CLVS in Q1 2017 and held it in 8 quarters. The position peaked at $4K in Q1 2019. 153 funds tracked by Wall St. Rank hold CLVS as of Q3 2019.

Proficio Capital Partners reported no remaining Clovis Oncology, Inc. position as of Q3 2019 after selling out during the quarter.
Proficio Capital Partners sold 55 Clovis Oncology, Inc. shares in Q3 2019, an estimated $1K.
Proficio Capital Partners first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 8 quarters.
Proficio Capital Partners's Clovis Oncology, Inc. position peaked at $4K in Q1 2019.
153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.